Project Debrief: Integrated C&Q Applied
On a Turn-Key Project
Format:
GoToWebinar
Instructions to join will be emailed one day prior
Moderator:
- Justin Cantor, Chief Strategy Officer, PSC Biotech
Speakers:
- James Golden PE, Project Design Lead (Process), CRB
- Matt Hoover, Project Director, CRB
- Kris McLinden, Validation Supervisor, GlaxoSmithKline
- Aaron Roth, Senior Project Manager, CAI
Cost to Attend:
- $25 ISPE Members
- $45 Non-Members
- $250 Webinar Sponsor
Session Description:
GSK (Owner), CRB (Design & Build), and CAI (C&Q) partnered from project detailed design stage to deliver a ~$100M “Turn-key” solution capital project, grounded in the principles of Integrated C&Q as defined in the ISPE Baseline Guide 5 2nd Edition. This will be a joint presentation from the respective project leads detailing one of the first large capital projects to adopt the new Baseline Guide and will cover the project approach to C&Q, practical lessons learned, wins and pitfalls. A number of key project decisions, and their cascading impacts throughout the project lifecycle will be covered, with particular emphasis on the importance of deliberate and timely user requirement definition, early alignment on project approach, and aggressive implementation of engineering quality process.
Please note: this is a pre-recorded webinar.